BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19194963)

  • 41. Sequencing of the ANKYRIN 3 gene (ANK3) encoding ankyrin G in bipolar disorder reveals a non-conservative amino acid change in a short isoform of ankyrin G.
    Dedman A; McQuillin A; Kandaswamy R; Sharp S; Anjorin A; Gurling H
    Am J Med Genet B Neuropsychiatr Genet; 2012 Apr; 159B(3):328-35. PubMed ID: 22328486
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Exonic DNA sequencing of ERBB4 in bipolar disorder.
    Goes FS; Rongione M; Chen YC; Karchin R; Elhaik E; ; Potash JB
    PLoS One; 2011; 6(5):e20242. PubMed ID: 21637803
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Systematic screening for DNA sequence variation in the coding region of the human dopamine transporter gene (DAT1).
    Grünhage F; Schulze TG; Müller DJ; Lanczik M; Franzek E; Albus M; Borrmann-Hassenbach M; Knapp M; Cichon S; Maier W; Rietschel M; Propping P; Nöthen MM
    Mol Psychiatry; 2000 May; 5(3):275-82. PubMed ID: 10889530
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association analysis of DAOA and DAO in bipolar disorder: results from two independent case-control studies.
    Gaysina D; Cohen-Woods S; Chow PC; Martucci L; Schosser A; Ball HA; Tozzi F; Perry J; Muglia P; Kennedy JL; King N; Vincent JB; Parikh SV; Strauss J; Craig IW; McGuffin P; Farmer A
    Bipolar Disord; 2010 Aug; 12(5):579-81. PubMed ID: 20712760
    [No Abstract]   [Full Text] [Related]  

  • 45. Analysis of ANK3 and CACNA1C variants identified in bipolar disorder whole genome sequence data.
    Fiorentino A; O'Brien NL; Locke DP; McQuillin A; Jarram A; Anjorin A; Kandaswamy R; Curtis D; Blizard RA; Gurling HM
    Bipolar Disord; 2014 Sep; 16(6):583-91. PubMed ID: 24716743
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Suggestive evidence for association between L-type voltage-gated calcium channel (CACNA1C) gene haplotypes and bipolar disorder in Latinos: a family-based association study.
    Gonzalez S; Xu C; Ramirez M; Zavala J; Armas R; Contreras SA; Contreras J; Dassori A; Leach RJ; Flores D; Jerez A; Raventós H; Ontiveros A; Nicolini H; Escamilla M
    Bipolar Disord; 2013 Mar; 15(2):206-14. PubMed ID: 23437964
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of D-amino acid oxidase activator (DAOA; G72) on brain function during verbal fluency.
    Prata DP; Papagni SA; Mechelli A; Fu CH; Kambeitz J; Picchioni M; Kane F; Kalidindi S; McDonald C; Kravariti E; Toulopoulou T; Bramon E; Walshe M; Murray R; Collier DA; McGuire PK
    Hum Brain Mapp; 2012 Jan; 33(1):143-53. PubMed ID: 21391259
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of DAOA polymorphisms with schizophrenia and clinical symptoms or therapeutic effects.
    Yue W; Kang G; Zhang Y; Qu M; Tang F; Han Y; Ruan Y; Lu T; Zhang J; Zhang D
    Neurosci Lett; 2007 Apr; 416(1):96-100. PubMed ID: 17293043
    [TBL] [Abstract][Full Text] [Related]  

  • 49. G72/G30 (DAOA) and juvenile-onset mood disorders.
    Gomez L; Wigg K; Feng Y; Kiss E; Kapornai K; Tamás Z; Mayer L; Baji I; Daróczi G; Benák I; Kothencné VO; Dombovári E; Kaczvinszk E; Besnyo M; Gádoros J; King N; Székely J; Kovacs M; Vetró A; Kennedy JL; Barr CL
    Am J Med Genet B Neuropsychiatr Genet; 2009 Oct; 150B(7):1007-12. PubMed ID: 19089835
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mutational screening and association study of glutamate decarboxylase 1 as a candidate susceptibility gene for bipolar affective disorder and schizophrenia.
    Lundorf MD; Buttenschøn HN; Foldager L; Blackwood DH; Muir WJ; Murray V; Pelosi AJ; Kruse TA; Ewald H; Mors O
    Am J Med Genet B Neuropsychiatr Genet; 2005 May; 135B(1):94-101. PubMed ID: 15806582
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association study of the G72 gene with schizophrenia in a Japanese population: a multicenter study.
    Ohi K; Hashimoto R; Yasuda Y; Yoshida T; Takahashi H; Iike N; Fukumoto M; Takamura H; Iwase M; Kamino K; Ishii R; Kazui H; Sekiyama R; Kitamura Y; Azechi M; Ikezawa K; Kurimoto R; Kamagata E; Tanimukai H; Tagami S; Morihara T; Ogasawara M; Okochi M; Tokunaga H; Numata S; Ikeda M; Ohnuma T; Ueno S; Fukunaga T; Tanaka T; Kudo T; Arai H; Ohmori T; Iwata N; Ozaki N; Takeda M
    Schizophr Res; 2009 Apr; 109(1-3):80-5. PubMed ID: 19237267
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of additional variants within the human dopamine transporter gene provides further evidence for an association with bipolar disorder in two independent samples.
    Greenwood TA; Schork NJ; Eskin E; Kelsoe JR
    Mol Psychiatry; 2006 Feb; 11(2):125-33, 115. PubMed ID: 16261167
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Structural, phylogenetic and docking studies of D-amino acid oxidase activator (DAOA), a candidate schizophrenia gene.
    Sehgal SA; Khattak NA; Mir A
    Theor Biol Med Model; 2013 Jan; 10():3. PubMed ID: 23286827
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association analysis of transcripts from the bipolar susceptibility locus on chromosome 4q35, exclusion of a pathogenic role for eight positional candidate genes.
    Blair IP; Badenhop RF; Scimone A; Moses MJ; Kerr NP; Donald JA; Mitchell PB; Schofield PR
    Am J Med Genet B Neuropsychiatr Genet; 2005 Apr; 134B(1):56-9. PubMed ID: 15717290
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Linkage disequilibrium mapping of bipolar affective disorder at 12q23-q24 provides evidence for association at CUX2 and FLJ32356.
    Glaser B; Kirov G; Green E; Craddock N; Owen MJ
    Am J Med Genet B Neuropsychiatr Genet; 2005 Jan; 132B(1):38-45. PubMed ID: 15389760
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tests of linkage and allelic association between markers in the 1p36 PRKCZ (protein kinase C zeta) gene region and bipolar affective disorder.
    Kandaswamy R; McQuillin A; Curtis D; Gurling H
    Am J Med Genet B Neuropsychiatr Genet; 2012 Mar; 159B(2):201-9. PubMed ID: 22231931
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The G72/G30 gene complex and cognitive abnormalities in schizophrenia.
    Goldberg TE; Straub RE; Callicott JH; Hariri A; Mattay VS; Bigelow L; Coppola R; Egan MF; Weinberger DR
    Neuropsychopharmacology; 2006 Sep; 31(9):2022-32. PubMed ID: 16554747
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Findings in an independent sample support an association between bipolar affective disorder and the G72/G30 locus on chromosome 13q33.
    Chen YS; Akula N; Detera-Wadleigh SD; Schulze TG; Thomas J; Potash JB; DePaulo JR; McInnis MG; Cox NJ; McMahon FJ
    Mol Psychiatry; 2004 Jan; 9(1):87-92; image 5. PubMed ID: 14699445
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Allelic association, DNA resequencing and copy number variation at the metabotropic glutamate receptor GRM7 gene locus in bipolar disorder.
    Kandaswamy R; McQuillin A; Curtis D; Gurling H
    Am J Med Genet B Neuropsychiatr Genet; 2014 Jun; 165B(4):365-72. PubMed ID: 24804643
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A combined study of genetic association and brain imaging on the DAOA gene in schizophrenia.
    Chen J; Xu Y; Zhang J; Liu Z; Xu C; Zhang K; Shen Y; Xu Q
    Am J Med Genet B Neuropsychiatr Genet; 2013 Mar; 162B(2):191-200. PubMed ID: 23335491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.